Monday, April 11, 2022

SARS-CoV-2: Neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies

Scientists studied the sensitivity of Omicron BA.1 and BA.2 to nine monoclonal antibodies, some of which are used in pre-exposure prophylaxis in immunocompromised individuals. The scientists showed a loss of neutralizing activity against BA.1 and BA.2 in people treated with two antibody cocktails.

from Top Health News -- ScienceDaily https://ift.tt/LZb82sE
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

They fled the flames—now jaguars rule a wetland refuge

After devastating wildfires scorched the Brazilian Pantanal, an unexpected phenomenon unfolded—more jaguars began arriving at a remote wetla...